Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gualandi

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|November 1, 1993
Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score)A Bacigalupo, F Gualandi, M T Van Lint, et al.
Bone Marrow Transplantation|July 1, 1995
CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortalityA Bacigalupo, E Tedone, A Isaza, et al.
Bone Marrow Transplantation|January 1, 1991
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemiaF Frassoni, A Bacigalupo, M Sessarego, et al.
Bone Marrow Transplantation|November 1, 1990
Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukemia in second remission: an updateA Bacigalupo, M T van Lint, F Frassoni, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|November 24, 2011
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathyG Vattemi, M Neri, S Piffer, et al.
British Journal of Haematology|October 1, 1989
The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantationF Frassoni, D Scarpati, A Bacigalupo, et al.
Bone Marrow Transplantation|March 1, 1994
Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxisF Fagioli, A Bacigalupo, F Frassoni, et al.
Bone Marrow Transplantation|June 1, 1994
CMV prophylaxis with foscarnet in allogeneic bone marrow transplant recipients at high risk of developing CMV infectionsA Bacigalupo, E Tedone, M T Van Lint, et al.
Haematologica|July 1, 1989
Bone marrow transplantation (BMT) for acute non lymphoid leukemia (ANLL) in first remission: an updateA Bacigalupo, M T Van Lint, F Frassoni, et al.
Annals of Hematology|March 1, 1992
Autologous and allogeneic bone marrow transplantation in acute myeloid leukemia in first complete remission: an update of the Genoa experience with 159 patientsA M Carella, F Frassoni, M T van Lint, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|November 1, 1993
Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score)A Bacigalupo, F Gualandi, M T Van Lint, et al.
Bone Marrow Transplantation|July 1, 1995
CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortalityA Bacigalupo, E Tedone, A Isaza, et al.
Bone Marrow Transplantation|January 1, 1991
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemiaF Frassoni, A Bacigalupo, M Sessarego, et al.
Bone Marrow Transplantation|November 1, 1990
Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukemia in second remission: an updateA Bacigalupo, M T van Lint, F Frassoni, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|November 24, 2011
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathyG Vattemi, M Neri, S Piffer, et al.
British Journal of Haematology|October 1, 1989
The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantationF Frassoni, D Scarpati, A Bacigalupo, et al.
Bone Marrow Transplantation|March 1, 1994
Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxisF Fagioli, A Bacigalupo, F Frassoni, et al.
Bone Marrow Transplantation|June 1, 1994
CMV prophylaxis with foscarnet in allogeneic bone marrow transplant recipients at high risk of developing CMV infectionsA Bacigalupo, E Tedone, M T Van Lint, et al.
Haematologica|July 1, 1989
Bone marrow transplantation (BMT) for acute non lymphoid leukemia (ANLL) in first remission: an updateA Bacigalupo, M T Van Lint, F Frassoni, et al.
Annals of Hematology|March 1, 1992
Autologous and allogeneic bone marrow transplantation in acute myeloid leukemia in first complete remission: an update of the Genoa experience with 159 patientsA M Carella, F Frassoni, M T van Lint, et al.
Pageof 14